Extracts from artemisia annua plant found to be active against SARS-CoV-2 virus under laboratory conditions
Harnessing the combined power of Vitamin C and TET proteins may give scientists a leg up in treating autoimmune diseases
21 July 2021Rethinking occupational welfare policies in long-term care organizations during pandemic
21 July 2021Extracts from artemisia annua plant found to be active against SARS-CoV-2 virus under laboratory conditions
A team of researchers affiliated with institutions in Denmark, Germany and Hong Kong has found that several extracts from the artemisia annua plant are active against the SARS-CoV-2 virus under laboratory conditions. In their paper published in the journal Scientific Reports, the group describes three extracts of the artemisia annua plant they tested and how they fared in combating the SARS-CoV-2 virus in human lung tissue. While the main focus of the pandemic has in recent months become the vaccines that are effective for prevention of COVID-19, work continues on treatments for those unvaccinated people who become infected with the SARS-CoV-2 virus.
